MOHAMED PATTAPPURATH: Open Payments
NPI 1851067805 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 24 payments from 8 companies in 2025. Trend: 2023 $484 · 2024 $311 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $339 |
| Otsuka America Pharmaceutical, Inc. | 4 | $115 |
| Alkermes, Inc. | 5 | $114 |
| Janssen Pharmaceuticals, Inc | 2 | $88 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Indivior Inc. | 1 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: UZEDY, ABILIFY MAINTENA, COBENFY, LYBALVI, SPRAVATO, ARISTADA, SUBLOCADE, ABILIFY ASIMTUFII.
Industry payments across AZ — which companies pay providers there.
